Baldwin R W, Embleton M J, Moore M
Br J Cancer. 1973 Nov;28(5):389-99. doi: 10.1038/bjc.1973.164.
The principal expression of immunity elicited in syngeneic rats immunized with rat hepatoma membrane fractions was the development of a tumour specific antibody response. This antibody was demonstrable by membrane immunofluorescence staining of viable hepatoma cells in suspension and the sera exhibited complement dependent cytotoxicity for cultured hepatoma cells. In the absence of complement, however, membrane immune sera were highly "blocking", protecting plated hepatoma cells from attack by sensitized lymph node cells. The cell mediated immune response elicited by hepatoma membrane immunization was weak, as evaluated by the colony inhibitory activity of lymph node cells for hepatoma cells in vitro or the adoptive transfer of immunity with peritoneal exudate cells. Correlated with this overall pattern of immune response, membrane immunization did not elicit tumour rejection reactions. These findings are relevant to current views that humoral factors operate antagonistically to limit cell mediated immunity to tumours. A further relevant feature was the observation that membrane immunization, eliciting a prominent humoral immune reaction, conditioned the recipients so that they subsequently failed to elicit a tumour rejection immunity on treatment with irradiated tumour cells.
用大鼠肝癌细胞膜组分免疫同基因大鼠所引发的主要免疫表现是肿瘤特异性抗体反应的发展。这种抗体可通过悬浮的活肝癌细胞的膜免疫荧光染色来证实,并且血清对培养的肝癌细胞表现出补体依赖性细胞毒性。然而,在没有补体的情况下,膜免疫血清具有高度的“阻断”作用,可保护接种的肝癌细胞免受致敏淋巴结细胞的攻击。通过体外淋巴结细胞对肝癌细胞的集落抑制活性或用腹腔渗出细胞进行免疫的过继转移评估,肝癌细胞膜免疫引发的细胞介导免疫反应较弱。与这种整体免疫反应模式相关,膜免疫并未引发肿瘤排斥反应。这些发现与当前的观点相关,即体液因子起拮抗作用以限制对肿瘤的细胞介导免疫。另一个相关特征是观察到,引发显著体液免疫反应的膜免疫使受体产生条件反应,以至于它们随后在用照射过的肿瘤细胞处理时未能引发肿瘤排斥免疫。